Poor Glycemic Control Is Associated With Increased Extracellular Volume Fraction in Diabetes

被引:22
作者
Al-Badri, Ahmed [1 ]
Hashmath, Zeba [2 ]
Oldland, Garrett H. [2 ,3 ,4 ]
Miller, Rachana [2 ,3 ,4 ]
Javaid, Khuzaima [2 ,3 ,4 ]
Syed, Amer Ahmed [5 ]
Ansari, Bilal [2 ]
Gaddam, Swetha [2 ]
Witschey, Walter R. [2 ,3 ]
Akers, Scott R. [4 ]
Chirinos, Julio A. [2 ,3 ,4 ]
机构
[1] Emory Univ, Sch Med, Atlanta, GA USA
[2] Hosp Univ Penn, 3400 Spruce St, Philadelphia, PA 19104 USA
[3] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
[4] Corporal Michael J Crescenz VA Med Ctr, Philadelphia, PA 19104 USA
[5] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
基金
美国国家卫生研究院;
关键词
LEFT-VENTRICULAR MASS; HEART-FAILURE; INSULIN-RESISTANCE; DIASTOLIC DYSFUNCTION; MYOCARDIAL FIBROSIS; CARDIAC FIBROSIS; MOUSE MODEL; MELLITUS; CARDIOMYOPATHY; COMPLICATIONS;
D O I
10.2337/dc18-0324
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVEWe assessed whether poor glycemic control is associated with an increase in myocardial fibrosis among adults with diabetes.RESEARCH DESIGN AND METHODSWe studied 47 adults with type 2 diabetes and stratified them into three groups according to their hemoglobin A1c (HbA(1c)) level: <6.5% (group 1; n = 12), 6.5-7.5% (group 2; n = 20), and >7.5% (group 3; n = 15). Left ventricular (LV) mass was assessed using cardiac MRI. The extracellular volume fraction (ECVF), an index of myocardial fibrosis, was measured by using myocardial T1 mapping before and after the administration of a gadolinium-based contrast agent.RESULTSMean HbA(1c) was 5.84 0.16%, 6.89 +/- 0.14%, and 8.57 +/- 0.2% in groups 1, 2, and 3, respectively. LV mass was not significantly different between the groups. The myocardial ECVF was significantly greater in groups 2 (mean 27.6% [95% CI 24.8-30.3]) and 3 (27.6% [24.4-30.8]) than in group 1 (21.1% [17.5-24.7]; P = 0.015). After adjusting for age, sex, BMI, blood pressure, and estimated glomerular filtration rate, the myocardial ECVF was significantly greater in groups 2 (27.4% [24.4-30.4]) and 3 (28% [24.5-31.5]) than in group 1 (20.9% [17.1-24.6]; P = 0.0156, ANCOVA).CONCLUSIONSAn increased myocardial ECVF, suggesting myocardial fibrosis, is independently associated with poor glycemic control among adults with diabetes. Further research should assess whether tight glycemic control can revert fibrosis to healthy myocardium or ameliorate it and its adverse clinical consequences.
引用
收藏
页码:2019 / 2025
页数:7
相关论文
共 42 条
[1]   Myocardial fibrosis and apoptosis, but not inflammation, are present in long-term experimental diabetes [J].
Ares-Carrasco, S. ;
Picatoste, B. ;
Benito-Martin, A. ;
Zubiri, I. ;
Sanz, A. B. ;
Sanchez-Nino, M. D. ;
Ortiz, A. ;
Egido, J. ;
Tunon, J. ;
Lorenzo, O. .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2009, 297 (06) :H2109-H2119
[2]   Association of Cardiovascular Risk Factors and Myocardial Fibrosis With Early Cardiac Dysfunction in Type 1 Diabetes: The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study [J].
Armstrong, Anderson C. ;
Ambale-Venkatesh, Bharath ;
Turkbey, Evrim ;
Donekal, Sirisha ;
Chamera, Elzbieta ;
Backlund, Jye-Yu ;
Cleary, Patricia ;
Lachin, John ;
Bluemke, David A. ;
Lima, Joao A. C. .
DIABETES CARE, 2017, 40 (03) :405-411
[3]   Impact of Diabetes Mellitus on Hospitalization for Heart Failure, Cardiovascular Events, and Death Outcomes at 4 Years From the Reduction of Atherothrombosis for Continued Health (REACH) Registry [J].
Cavender, Matthew A. ;
Steg, Ph Gabriel ;
Smith, Sidney C., Jr. ;
Eagle, Kim ;
Ohman, E. Magnus ;
Goto, Shinya ;
Kuder, Julia ;
Im, Kyungah ;
Wilson, Peter W. F. ;
Bhatt, Deepak L. .
CIRCULATION, 2015, 132 (10) :923-931
[4]   Myocardial Fibrosis and Cardiac Decompensation in Aortic Stenosis [J].
Chin, Calvin W. L. ;
Everett, Russell J. ;
Kwiecinski, Jacek ;
Vesey, Alex T. ;
Yeung, Emily ;
Esson, Gavin ;
Jenkins, William ;
Koo, Maria ;
Mirsadraee, Saeed ;
White, Audrey C. ;
Japp, Alan G. ;
Prasad, Sanjay K. ;
Semple, Scott ;
Newby, David E. ;
Dweck, Marc R. .
JACC-CARDIOVASCULAR IMAGING, 2017, 10 (11) :1320-1333
[5]  
Chirinos JA, 2016, J AM HEART ASS, V5
[6]   Left Ventricular Mass Allometric Scaling, Normative Values, Effect of Obesity, and Prognostic Performance [J].
Chirinos, Julio A. ;
Segers, Patrick ;
De Buyzere, Marc L. ;
Kronmal, Richard A. ;
Raja, Muhammad W. ;
De Bacquer, Dirk ;
Claessens, Tom ;
Gillebert, Thierry C. ;
St John-Sutton, Martin ;
Rietzschel, Ernst R. .
HYPERTENSION, 2010, 56 (01) :91-U137
[7]   Hypoglycemia and Cardiovascular Risks [J].
Frier, Brian M. ;
Schernthaner, Guntram ;
Heller, Simon R. .
DIABETES CARE, 2011, 34 :S132-S137
[8]   Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review [J].
Haaf, Philip ;
Garg, Pankaj ;
Messroghli, Daniel R. ;
Broadbent, David A. ;
Greenwood, John P. ;
Plein, Sven .
JOURNAL OF CARDIOVASCULAR MAGNETIC RESONANCE, 2016, 18
[9]   Follow-up of Glycemic Control and Cardiovascular Outcomes in Type 2 Diabetes [J].
Hayward, Rodney A. ;
Reaven, Peter D. ;
Wiitala, Wyndy L. ;
Bahn, Gideon D. ;
Reda, Domenic J. ;
Ge, Ling ;
McCarren, Madeline ;
Duckworth, William C. ;
Emanuele, Nicholas V. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (23) :2197-2206
[10]   Cardiac-Specific IGF-1 Receptor Transgenic Expression Protects Against Cardiac Fibrosis and Diastolic Dysfunction in a Mouse Model of Diabetic Cardiomyopathy [J].
Huynh, Karina ;
McMullen, Julie R. ;
Julius, Tracey L. ;
Tan, Joon Win ;
Love, Jane E. ;
Cemerlang, Nelly ;
Kiriazis, Helen ;
Du, Xiao-Jun ;
Ritchie, Rebecca H. .
DIABETES, 2010, 59 (06) :1512-1520